A press event at the White House on Nov. 6, led by former President Donald Trump and health officials to unveil a weight-loss drug pricing deal, was abruptly interrupted when a male attendee collapsed in the Oval Office. The incident occurred while an executive from Eli Lilly was speaking; the man was later identified as an industry representative and was reported to be fine after being treated onsite.
Dr. Mehmet Oz, who heads the Centers for Medicare & Medicaid Services, and White House medical staff responded immediately, assisting the individual and pausing the live event. Streams were cut off as the venue shifted to manage the situation.
Trump addressed the incident after the announcement resumed, stating the individual had been “a little bit light-headed” and confirmed he was receiving care. The pharmaceutical company involved clarified the person was not a Novo Nordisk executive, countering initial speculation.
The disruption drew widespread attention and raised questions about event safety and health protocols during high-profile government ceremonies.